Advanced Life Sciences Report issue

For profit Phase 1 Phase 3
Founded: Woodridge IL United States (1998)
Status: Defunct (2012)

Organization Overview

First Clinical Trial
2005
NCT00336505
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Alternative names

Advanced Life Sciences, Inc.

Active Ingredients

Drugs in Phase 3 Trials (2)

cethromycin (Restanza) (2 trials)

clarithromycin (biaxin) (2 trials)

Drugs in Phase 1 Trials (1)

betulinic acid (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Melanoma (Phase 1)

Pneumonia (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 3